மையம் க்கு அளவு மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மையம் க்கு அளவு மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மையம் க்கு அளவு மருந்து Today - Breaking & Trending Today

New study launched to more accurately diagnose early hepatocellular carcinoma

New study launched to more accurately diagnose early hepatocellular carcinoma
A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual s likelihood of developing the cancer. HCC is the sixth most common cancer in the world but the third most common cause of cancer deaths globally. In Singapore, HCC is the third and fourth most common cause of cancer deaths, amongst males and females respectively.
While potentially curative treatment is possible with early diagnosis, only 20% of HCC cases are detected at a stage where cure is possible. This investigator-initiated multi-centre study led by the National Cancer Centre of Singapore (NCCS) called EarLy DEtection of HCC: miRNA, microbiome and imaGing biomArkers in the evolution of chroNiC livEr Disease in a high-risk prospective cohort (ELEGANCE), addr ....

National University Hospital , Singapore General , Marine Parade , Tan Tock Seng Hospital , Bukit Merah , Mihir Gandhi , Asia Pacific , Wang Yulan , Emily Henderson , Dan Yock Young , Jason Chang Pik , Centre For Quantitative Medicine , Division Of Gastroenterology , Agency Of Science , Lee Kong Chian School Of Medicine , National Cancer Centre Of Singapore , Nanyang Technological University Singapore , Singapore Phenome Centre , Department Of Gastroenterology Hepatology , National Cancer Centre Singapore , Division Of Surgery , Health Services Systems Research Signature Programme , National Cancer Centre , Pierce Chow , Principal Investigator , Senior Consultant ,

Landmark study launched to detect liver cancer early in Singapore

E-Mail
IMAGE: Quantitative MR images of the liver from six patients presenting with liver cancer produced by Perspectum s LiverMultiScan which will be used in a new study led by National Cancer Centre.
view more
Credit: Image credit: Mole DJ et al. Plos One. 2020;15(12):e0238568
Only 20% of primary liver cancer or hepatocellular carcinoma (HCC) are diagnosed at an early stage, which makes early detection an urgent, unmet healthcare need.
Study aims to develop more accurate diagnostics for early HCC, an AI algorithm to predict an individual s risk of developing HCC, and discover novel molecular targets to prevent the development of HCC. ....

National University Hospital , Singapore General , Marine Parade , Tan Tock Seng Hospital , Bukit Merah , National University Of Singapore , City Of , United Kingdom , Dharshini Subbiah , Shireen Federico , Dan Yock Young , Wang Yulan , Jason Chang Pik , Mihir Gandhi , Asia Pacific , Perspectum Livermultiscan , Yu Zehan , Duke University School Of Medicine , National Registry Of Diseases Office , Nanyang Technological University , Agency Of Science , Lee Kong Chian School Of Medicine , National Institute Of Education , Department Of Gastroenterology Hepatology , Singapore Centre For Environmental Life Sciences Engineering , Division Of Surgery ,

Landscape study launched to detect liver cancer early in Singapore

E-Mail
IMAGE: Quantitative MR images of the liver from six patients presenting with liver cancer produced by Perspectum s LiverMultiScan which will be used in a new study led by National Cancer Centre.
view more
Credit: Mole DJ et al. Plos One. 2020;15(12):e0238568
Singapore, 3 May 2021 - A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual s likelihood of developing the cancer. HCC is the sixth most common cancer in the world but the third most common cause of cancer deaths globally.[1] In Singapore, HCC is the third and fourth most common cause of cancer deaths, amongst males and females respectively.[2] While potentially curative treatment is possible with early diagnosis, only 20% of HCC cases are detected at a stage where cure is possible. This investigator-initiated ....

National University Hospital , Singapore General , Marine Parade , Tan Tock Seng Hospital , Bukit Merah , Mihir Gandhi , Asia Pacific , Wang Yulan , Dan Yock Young , Jason Chang Pik , Centre For Quantitative Medicine , National Registry Of Diseases Office , Division Of Gastroenterology , Agency Of Science , Lee Kong Chian School Of Medicine , National Cancer Centre Of Singapore , Nanyang Technological University Singapore , Singapore Phenome Centre , Department Of Gastroenterology Hepatology , National Cancer Centre Singapore , Division Of Surgery , Health Services Systems Research Signature Programme , National Cancer Centre , Prof Pierce Chow , Principal Investigator , Senior Consultant ,

LANDMARK STUDY LAUNCHED TO DETECT LIVER CANCER EARLY IN SINGAPORE

LANDMARK STUDY LAUNCHED TO DETECT LIVER CANCER EARLY IN SINGAPORE
asiaresearchnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaresearchnews.com Daily Mail and Mail on Sunday newspapers.

National University Hospital , Singapore General , Marine Parade , Tan Tock Seng Hospital , Bukit Merah , Mihir Gandhi , Asia Pacific , Wang Yulan , Dan Yock Young , Jason Chang Pik , Centre For Quantitative Medicine , Division Of Gastroenterology , Agency Of Science , Lee Kong Chian School Of Medicine , National Cancer Centre Of Singapore , Nanyang Technological University Singapore , Singapore Phenome Centre , Department Of Gastroenterology Hepatology , National Cancer Centre Singapore , Division Of Surgery , Health Services Systems Research Signature Programme , National Cancer Centre , Prof Pierce Chow , Principal Investigator , Senior Consultant , Surgical Oncology ,

COVID is down in Connecticut, but it's unclear why

COVID is down sharply in CT. No one knows exactly why.
FacebookTwitterEmail
1of5
Maryanne Lenhardt gets a COVID-19 vaccination, Wednesday, Feb. 10, 2021, at Central High School in Bridgeport, Conn. The mass vaccination clinic is one of several ways Bridgeport officials are trying to fight the low vaccination rates many cities across the country are seeing compared with wealthier suburbs. (AP Photo/Mark Lennihan)Mark Lennihan / Associated PressShow MoreShow Less
2of5
Fifty individuals 75 and older received their COVID-19 vaccine Tuesday morning at Cross Street AME Zion Church in Middletown, as part of the city s effort to inoculate older members of the congregation. The Black community has a longstanding distrust of the medical system, according to the Rev. Robyn Anderson, director of the Ministerial Health Fellowship.Cassandra Day / Hearst Connecticut MediaShow MoreShow Less ....

United States , Yale New Haven Hospital , Pedro Mendes , Richard Martinello , Ned Lamont , Uconn Center , Yale New Haven , Thanksgiving Christmas New Year , Andy Slavitt , Joe Biden , B 1 351 , South Africa , United Kingdom , Covid 19 , Fairfield Citizen News , Westport News , Trumbull Times , Darien Times , Ridgefield Press , Wilton Bulletin , Shelton Herald , Milford Mirror , New Canaan Advertiser , Center For Quantitative Medicine , Co Vid , B 1 7 ,